3-mercaptopyruvic acid has been researched along with Disease Models, Animal in 3 studies
3-mercaptopyruvic acid: RN given refers to parent cpd; structure
3-mercaptopyruvic acid : A 2-oxo monocarboxylic acid that is pyruvic acid substituted by a sulfanyl group at position 3.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hemorrhagic shock is a major cause of death after trauma." | 1.51 | The Effects of Genetic 3-Mercaptopyruvate Sulfurtransferase Deficiency in Murine Traumatic-Hemorrhagic Shock. ( Calzia, E; Georgieff, M; Gröger, M; Hafner, S; Hartmann, C; Huber-Lang, M; Kress, S; Lukaschewski, B; McCook, O; Merz, T; Nagahara, N; Radermacher, P; Szabó, C; Wachter, U; Wepler, M, 2019) |
| "Hemorrhagic shock was implemented for 1 h followed by retransfusion of shed blood and intensive care therapy for 4 h, including lung-protective mechanical ventilation, fluid resuscitation, and noradrenaline titrated to maintain a mean arterial pressure at least 50 mmHg." | 1.51 | The Effects of Genetic 3-Mercaptopyruvate Sulfurtransferase Deficiency in Murine Traumatic-Hemorrhagic Shock. ( Calzia, E; Georgieff, M; Gröger, M; Hafner, S; Hartmann, C; Huber-Lang, M; Kress, S; Lukaschewski, B; McCook, O; Merz, T; Nagahara, N; Radermacher, P; Szabó, C; Wachter, U; Wepler, M, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gröger, M | 1 |
| Wepler, M | 1 |
| Wachter, U | 1 |
| Merz, T | 1 |
| McCook, O | 1 |
| Kress, S | 1 |
| Lukaschewski, B | 1 |
| Hafner, S | 1 |
| Huber-Lang, M | 1 |
| Calzia, E | 1 |
| Georgieff, M | 1 |
| Nagahara, N | 1 |
| Szabó, C | 2 |
| Radermacher, P | 1 |
| Hartmann, C | 1 |
| Coletta, C | 1 |
| Módis, K | 1 |
| Szczesny, B | 1 |
| Brunyánszki, A | 1 |
| Oláh, G | 1 |
| Rios, EC | 1 |
| Yanagi, K | 1 |
| Ahmad, A | 1 |
| Papapetropoulos, A | 1 |
| Chan, A | 1 |
| Crankshaw, DL | 1 |
| Monteil, A | 1 |
| Patterson, SE | 1 |
| Nagasawa, HT | 1 |
| Briggs, JE | 1 |
| Kozocas, JA | 1 |
| Mahon, SB | 1 |
| Brenner, M | 1 |
| Pilz, RB | 1 |
| Bigby, TD | 1 |
| Boss, GR | 1 |
3 other studies available for 3-mercaptopyruvic acid and Disease Models, Animal
| Article | Year |
|---|---|
The Effects of Genetic 3-Mercaptopyruvate Sulfurtransferase Deficiency in Murine Traumatic-Hemorrhagic Shock.
Topics: Animals; Cysteine; Disease Models, Animal; Female; Immunohistochemistry; Male; Mice; Mitochondria; M | 2019 |
Regulation of Vascular Tone, Angiogenesis and Cellular Bioenergetics by the 3-Mercaptopyruvate Sulfurtransferase/H2S Pathway: Functional Impairment by Hyperglycemia and Restoration by DL-α-Lipoic Acid.
Topics: Animals; Cell Line; Cyclic GMP-Dependent Protein Kinases; Cysteine; Diabetes Mellitus; Disease Model | 2015 |
The combination of cobinamide and sulfanegen is highly effective in mouse models of cyanide poisoning.
Topics: Animals; Antidotes; Cobamides; Cyanides; Cysteine; Disease Models, Animal; Drug Therapy, Combination | 2011 |